Fulgent Genetics Inc (FLGT)
20.76
+0.12
(+0.56%)
USD |
NASDAQ |
Apr 24, 16:00
20.76
0.00 (0.00%)
After-Hours: 20:00
Fulgent Genetics Research and Development Expense (Quarterly): 11.95M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.95M |
| September 30, 2023 | 10.01M |
| June 30, 2023 | 9.692M |
| March 31, 2023 | 9.782M |
| December 31, 2022 | 8.509M |
| September 30, 2022 | 7.507M |
| June 30, 2022 | 6.905M |
| March 31, 2022 | 5.989M |
| December 31, 2021 | 7.464M |
| September 30, 2021 | 6.021M |
| June 30, 2021 | 5.312M |
| March 31, 2021 | 5.422M |
| December 31, 2020 | 4.576M |
| September 30, 2020 | 3.177M |
| June 30, 2020 | 1.849M |
| March 31, 2020 | 1.978M |
| December 31, 2019 | 1.795M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.744M |
| June 30, 2019 | 1.574M |
| March 31, 2019 | 1.424M |
| December 31, 2018 | 1.426M |
| September 30, 2018 | 1.438M |
| June 30, 2018 | 1.212M |
| March 31, 2018 | 1.458M |
| December 31, 2017 | 1.324M |
| September 30, 2017 | 1.128M |
| June 30, 2017 | 0.92M |
| March 31, 2017 | 0.851M |
| December 31, 2016 | 0.819M |
| September 30, 2016 | 1.523M |
| June 30, 2016 | 0.656M |
| March 31, 2016 | 0.561M |
| December 31, 2015 | 3.649M |
| September 30, 2015 | 0.311M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.574M
Minimum
Jun 2019
11.95M
Maximum
Dec 2023
5.856M
Average
5.989M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| Delcath Systems Inc | 4.709M |
| Star Equity Holdings Inc | -- |
| Exact Sciences Corp | 114.92M |
| CytoSorbents Corp | 4.096M |
| Progyny Inc | -- |